Differential effects of opiate agonists-antagonists on morphine-induced hyperexcitability and analgesia in mice
- 1 April 1981
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 73 (2) , 134-136
- https://doi.org/10.1007/bf00429203
Abstract
The effects of two opiate agonists-antagonists, butorphanol (4.0 and 8.0 mg/kg) and buprenorphine (0.1 and 1.0 mg/kg), were assessed on locomotor activity and analgesia in DBA/2 and C57BL/6 mice. Diferrent behavioral effects were evident in these strains, which might becharacterized by different reactions to the effects of opiates and by differences in endorphin distributions and opiate receptor populations. In particular, buprenorphine acted as an agonist-antagonist to morphine in both strains while a dissociation of buturphanol effects was evident, depending on the strain considered. The clinical implications of these findings are discussed.This publication has 12 references indexed in Scilit:
- Genotype-dependent sensitivity to morphine: role of different opiate receptor populationsBrain Research, 1980
- Buprenorphine Suppresses Heroin Use by Heroin AddictsScience, 1980
- Differential effects of localized lesions of n. accumbens on morphine- and amphetamine-induced locomotor hyperactivity in the C57BL/6J mouse.Journal of Comparative and Physiological Psychology, 1979
- Analgesic effectiveness of the narcotic agonist‐antagonists.British Journal of Clinical Pharmacology, 1979
- History and development of mixed opioid agonists, partial agonists and antagonists.British Journal of Clinical Pharmacology, 1979
- Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs.Published by Wiley ,1979
- Mixed agonist-antagonist opiates and physical dependence.Published by Wiley ,1979
- THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENTBritish Journal of Pharmacology, 1977
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977
- Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.1973